Sensitive high-performance liquid chromatographic determination of nifedipine in dog plasma using an automated sample preparation system with laboratory robot. 1996

V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
Technical University of Budapest, Institute for General and Analytical Chemistry, Hungary.

Nifedipine, a calcium-channel blocking drug was analysed in dog plasma after oral dosing with two different formulations. Sample preparation was automated with a laboratory robot. Quantitative determination of the drug was performed on a reversed-phase HPLC system with electrochemical detection (ED) using an internal standard. Validation of the analytical method showed that the system is well suited for pharmacokinetic studies on dogs. The assay was linear in the range 1-50 ng/ml. Inter-day and intra-day variability were between 6.43-18.15% C.V. and 1.57-5.53% C.V., respectively.

UI MeSH Term Description Entries
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D012015 Reference Standards A basis of value established for the measure of quantity, weight, extent or quality, e.g. weight standards, standard solutions, methods, techniques, and procedures used in diagnosis and therapy. Standard Preparations,Standards, Reference,Preparations, Standard,Standardization,Standards,Preparation, Standard,Reference Standard,Standard Preparation,Standard, Reference
D002121 Calcium Channel Blockers A class of drugs that act by selective inhibition of calcium influx through cellular membranes. Calcium Antagonists, Exogenous,Calcium Blockaders, Exogenous,Calcium Channel Antagonist,Calcium Channel Blocker,Calcium Channel Blocking Drug,Calcium Inhibitors, Exogenous,Channel Blockers, Calcium,Exogenous Calcium Blockader,Exogenous Calcium Inhibitor,Calcium Channel Antagonists,Calcium Channel Blocking Drugs,Exogenous Calcium Antagonists,Exogenous Calcium Blockaders,Exogenous Calcium Inhibitors,Antagonist, Calcium Channel,Antagonists, Calcium Channel,Antagonists, Exogenous Calcium,Blockader, Exogenous Calcium,Blocker, Calcium Channel,Blockers, Calcium Channel,Calcium Blockader, Exogenous,Calcium Inhibitor, Exogenous,Channel Antagonist, Calcium,Channel Blocker, Calcium,Inhibitor, Exogenous Calcium
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D004563 Electrochemistry The study of chemical changes resulting from electrical action and electrical activity resulting from chemical changes. Electrochemistries
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012371 Robotics The application of electronic, computerized control systems to mechanical devices designed to perform human functions. Formerly restricted to industry, but nowadays applied to artificial organs controlled by bionic (bioelectronic) devices, like automated insulin pumps and other prostheses. Companion Robots,Humanoid Robots,Remote Operations (Robotics),Social Robots,Socially Assistive Robots,Telerobotics,Soft Robotics,Assistive Robot, Socially,Companion Robot,Humanoid Robot,Operation, Remote (Robotics),Operations, Remote (Robotics),Remote Operation (Robotics),Robot, Companion,Robot, Humanoid,Robot, Social,Robot, Socially Assistive,Robotic, Soft,Social Robot,Socially Assistive Robot,Soft Robotic
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014665 Vasodilator Agents Drugs used to cause dilation of the blood vessels. Vasoactive Antagonists,Vasodilator,Vasodilator Agent,Vasodilator Drug,Vasorelaxant,Vasodilator Drugs,Vasodilators,Vasorelaxants,Agent, Vasodilator,Agents, Vasodilator,Antagonists, Vasoactive,Drug, Vasodilator,Drugs, Vasodilator

Related Publications

V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
June 1999, Journal of chromatography. B, Biomedical sciences and applications,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
September 1984, Journal of chromatography,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
August 1993, Journal of chromatography,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
December 2002, Journal of biochemical and biophysical methods,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
March 1986, Journal of chromatography,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
January 1985, Therapeutic drug monitoring,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
January 1991, Biomedical chromatography : BMC,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
July 1993, Journal of chromatography,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
December 1986, Journal of chromatography,
V Horváth, and A Hrabéczy-Páll, and Z Niegreisz, and E Kocsi, and G Horvai, and L Gödörházy, and A Tolokán, and I Klebovich, and K Balogh-Nemes
April 1990, Journal of chromatography,
Copied contents to your clipboard!